AMERICAN WELL CORP-CLASS A (AMWL) Fundamental Analysis & Valuation

NYSE:AMWL • US03044L2043

Current stock price

5.62 USD
+0.13 (+2.37%)
Last:

This AMWL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AMWL Profitability Analysis

1.1 Basic Checks

  • AMWL had negative earnings in the past year.
  • In the past year AMWL has reported a negative cash flow from operations.
  • In the past 5 years AMWL always reported negative net income.
  • In the past 5 years AMWL always reported negative operating cash flow.
AMWL Yearly Net Income VS EBIT VS OCF VS FCFAMWL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -200M -400M -600M

1.2 Ratios

  • AMWL has a Return On Assets of -29.56%. This is comparable to the rest of the industry: AMWL outperforms 42.86% of its industry peers.
  • AMWL has a Return On Equity of -40.62%. This is comparable to the rest of the industry: AMWL outperforms 54.29% of its industry peers.
Industry RankSector Rank
ROA -29.56%
ROE -40.62%
ROIC N/A
ROA(3y)-63.93%
ROA(5y)-45.24%
ROE(3y)-84.79%
ROE(5y)-58.8%
ROIC(3y)N/A
ROIC(5y)N/A
AMWL Yearly ROA, ROE, ROICAMWL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100

1.3 Margins

  • AMWL's Gross Margin of 53.79% is on the low side compared to the rest of the industry. AMWL is outperformed by 62.86% of its industry peers.
  • In the last couple of years the Gross Margin of AMWL has grown nicely.
  • The Profit Margin and Operating Margin are not available for AMWL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.48%
GM growth 5Y6.88%
AMWL Yearly Profit, Operating, Gross MarginsAMWL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. AMWL Health Analysis

2.1 Basic Checks

  • AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AMWL has been increased compared to 1 year ago.
  • AMWL has less shares outstanding than it did 5 years ago.
  • AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMWL Yearly Shares OutstandingAMWL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
AMWL Yearly Total Debt VS Total AssetsAMWL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • AMWL has an Altman-Z score of -7.84. This is a bad value and indicates that AMWL is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AMWL (-7.84) is worse than 85.71% of its industry peers.
  • There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.84
ROIC/WACCN/A
WACC9.52%
AMWL Yearly LT Debt VS Equity VS FCFAMWL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 3.37 indicates that AMWL has no problem at all paying its short term obligations.
  • AMWL has a Current ratio of 3.37. This is in the better half of the industry: AMWL outperforms 77.14% of its industry peers.
  • AMWL has a Quick Ratio of 3.35. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.
  • AMWL has a Quick ratio of 3.35. This is in the better half of the industry: AMWL outperforms 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.35
AMWL Yearly Current Assets VS Current LiabilitesAMWL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. AMWL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 52.57% over the past year.
  • AMWL shows a decrease in Revenue. In the last year, the revenue decreased by -1.98%.
  • Measured over the past years, AMWL shows a small growth in Revenue. The Revenue has been growing by 0.33% on average per year.
EPS 1Y (TTM)52.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.13%
Revenue 1Y (TTM)-1.98%
Revenue growth 3Y-3.47%
Revenue growth 5Y0.33%
Sales Q2Q%-22.11%

3.2 Future

  • AMWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.10% yearly.
  • AMWL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.60% yearly.
EPS Next Y34.92%
EPS Next 2Y23.79%
EPS Next 3Y18.72%
EPS Next 5Y11.1%
Revenue Next Year-19.18%
Revenue Next 2Y-8.22%
Revenue Next 3Y-4.1%
Revenue Next 5Y-1.6%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMWL Yearly Revenue VS EstimatesAMWL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
AMWL Yearly EPS VS EstimatesAMWL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -10 -20 -30 -40

More info and screens

Find the best growth stocksShow best growing peers

0

4. AMWL Valuation Analysis

4.1 Price/Earnings Ratio

  • AMWL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMWL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMWL Price Earnings VS Forward Price EarningsAMWL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMWL Per share dataAMWL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AMWL's earnings are expected to grow with 18.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.79%
EPS Next 3Y18.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMWL Dividend Analysis

5.1 Amount

  • AMWL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMWL Fundamentals: All Metrics, Ratios and Statistics

AMERICAN WELL CORP-CLASS A

NYSE:AMWL (3/13/2026, 8:09:47 PM)

5.62

+0.13 (+2.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners38.93%
Inst Owner Change0%
Ins Owners3.54%
Ins Owner Change1.41%
Market Cap93.01M
Revenue(TTM)249.32M
Net Income(TTM)-95.70M
Analysts70.67
Price Target6.63 (17.97%)
Short Float %2.58%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.58%
Min EPS beat(2)-9.03%
Max EPS beat(2)16.19%
EPS beat(4)3
Avg EPS beat(4)17.14%
Min EPS beat(4)-9.03%
Max EPS beat(4)31.2%
EPS beat(8)6
Avg EPS beat(8)10.13%
EPS beat(12)7
Avg EPS beat(12)-7.06%
EPS beat(16)10
Avg EPS beat(16)-4.37%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.14%
Max Revenue beat(2)2.89%
Revenue beat(4)4
Avg Revenue beat(4)5.4%
Min Revenue beat(4)1.14%
Max Revenue beat(4)8.93%
Revenue beat(8)5
Avg Revenue beat(8)2.14%
Revenue beat(12)5
Avg Revenue beat(12)0.15%
Revenue beat(16)5
Avg Revenue beat(16)-0.22%
PT rev (1m)-20.41%
PT rev (3m)-27.1%
EPS NQ rev (1m)12.58%
EPS NQ rev (3m)11.58%
EPS NY rev (1m)8.93%
EPS NY rev (3m)7.93%
Revenue NQ rev (1m)-10.95%
Revenue NQ rev (3m)-10.95%
Revenue NY rev (1m)-17.07%
Revenue NY rev (3m)-17.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)-6.64
EYN/A
EPS(NY)-4.32
Fwd EYN/A
FCF(TTM)-3.99
FCFYN/A
OCF(TTM)-3.99
OCFYN/A
SpS15.06
BVpS14.23
TBVpS10.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.56%
ROE -40.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.79%
FCFM N/A
ROA(3y)-63.93%
ROA(5y)-45.24%
ROE(3y)-84.79%
ROE(5y)-58.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.48%
GM growth 5Y6.88%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.06%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 3.35
Altman-Z -7.84
F-Score6
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)31.54%
Cap/Depr(5y)27.61%
Cap/Sales(3y)3.96%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.13%
EPS Next Y34.92%
EPS Next 2Y23.79%
EPS Next 3Y18.72%
EPS Next 5Y11.1%
Revenue 1Y (TTM)-1.98%
Revenue growth 3Y-3.47%
Revenue growth 5Y0.33%
Sales Q2Q%-22.11%
Revenue Next Year-19.18%
Revenue Next 2Y-8.22%
Revenue Next 3Y-4.1%
Revenue Next 5Y-1.6%
EBIT growth 1Y55.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.27%
EBIT Next 3Y24.78%
EBIT Next 5Y16.34%
FCF growth 1Y53.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.21%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAN WELL CORP-CLASS A / AMWL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AMERICAN WELL CORP-CLASS A?

ChartMill assigns a fundamental rating of 3 / 10 to AMWL.


Can you provide the valuation status for AMERICAN WELL CORP-CLASS A?

ChartMill assigns a valuation rating of 0 / 10 to AMERICAN WELL CORP-CLASS A (AMWL). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAN WELL CORP-CLASS A?

AMERICAN WELL CORP-CLASS A (AMWL) has a profitability rating of 1 / 10.